Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | KLF2 |
| Upstream (Parents) |
|---|
| (<<) AKAP12 → KLF2 |
| (<<) ALOX15B → KLF2 |
| (<<) AXL → KLF2 |
| (<<) CBFA2T3 → KLF2 |
| (<<) CD4 → KLF2 |
| (<<) CLDN5 → KLF2 |
| (<<) FZD4 → KLF2 |
| (<<) HSPA14 → KLF2 |
| (<<) IGFBP6 → KLF2 |
| (<<) IGFBP7 → KLF2 |
| (<<) ITGB8 → KLF2 |
| (<<) KLHL7 → KLF2 |
| (<<) LYAR → KLF2 |
| (<<) MMP28 → KLF2 |
| (<<) MN1 → KLF2 |
| (<<) MXRA8 → KLF2 |
| (<<) ORC6L → KLF2 |
| (<<) RHOB → KLF2 |
| (<<) SH3TC1 → KLF2 |
| (<<) SOX17 → KLF2 |
| (<<) SPDEF → KLF2 |
| Downstream (Children) |
|---|
| KLF2 → ABLIM1 (>>) |
| KLF2 → ACTC1 (>>) |
| KLF2 → CEBPA (>>) |
| KLF2 → DNM1L (>>) |
| KLF2 → DUSP1 (>>) |
| KLF2 → DUSP5 (>>) |
| KLF2 → EGF (>>) |
| KLF2 → EGR1 (>>) |
| KLF2 → FERMT1 (>>) |
| KLF2 → FOS (>>) |
| KLF2 → GNAI1 (>>) |
| KLF2 → HS3ST1 (>>) |
| KLF2 → ITGA7 (>>) |
| KLF2 → JUNB (>>) |
| KLF2 → KLF4 (>>) |
| KLF2 → MAP3K12 (>>) |
| KLF2 → MAP3K3 (>>) |
| KLF2 → MTSS1 (>>) |
| KLF2 → NFIL3 (>>) |
| KLF2 → PDE2A (>>) |
| KLF2 → RNF138 (>>) |
| KLF2 → SEH1L (>>) |
| KLF2 → SOD3 (>>) |
| KLF2 → TARS (>>) |
| KLF2 → TRERF1 (>>) |
| KLF2 → ZFP36 (>>) |
